WHO has prequalified two rapid COVID-19 antigen tests, confirming their safety and quality and expanding access to fast, ...
The assay is the first to receive FDA 510(k) clearance and CLIA waiver for use with Diasorin's Liaison Nes platform.
The assay is the first to receive FDA 510(k) clearance and CLIA waiver for use with Diasorin's Liaison Nes platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback